title: Development of federally mandated risk evaluation and mitigation strategies (REMS) for transmucosal immediate-release fentanyl products.
authors: Joseph V
authors: JV
authors: Pergolizzi
authors: Christopher G
authors: CG
authors: Gharibo
authors: Jeffrey A
authors: JA
authors: Gudin
authors: Srinivas R
authors: SR
authors: Nalamachu
mesh_terms: D058956:Administration, Mucosal; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D005283:Fentanyl / Q000008:administration & dosage*; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D060735:Pharmacovigilance; D012308:Risk Management / Q000379:methods*; D014481:United States
chemical_list: D000701:Analgesics, Opioid; D005283:Fentanyl